
Medical-gear makers are sharing production information and receiving protection from antitrust scrutiny, the companies and federal officials stated, as part of government efforts to better coordinate the distribution of N95 masks and other supplies, reported The Wall Street Journal.
The Federal Emergency Management Agency announced that it convened major N95 producers, distributors, and buyers last week for a first meeting to discuss the mask supply chain. That group is a subset of nearly 60 companies and trade groups that will share information on production, distribution, and pricing for in-demand medical products, FEMA stated.
The agreement is part of the federal government’s efforts to better coordinate the production and distribution of medical-grade face masks, which have become critical equipment for people treating COVID-19 patients. The effort includes big manufacturers, such as 3MCo. and Honeywell International , both of which have ramped up production of N95s and other protective gear this year. Masks and other gear remain in short supply as COVID-19 cases and hospitalizations hover near peak levels across much of the country.
The project is operating under a provision of the Defense Production Act that allows the federal government to consult with businesses for emergency preparedness and response. President Trump invoked that part of the law by executive order in March.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas